Not Tagged
novartis
['mds', 'novartis']
at #ash22, from presents data from a randomized phase ii trial of a novel immunotherapy in patients with higher-risk #mdssm 
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu